Business Context and Reporting Period
Company: Bristol-Myers Squibb Company
Filing Type: Form 8-K (Current Report)
Date of Report: May 8, 2006
Reporting Period: This filing serves as a current report to submit XBRL-formatted documents related to the Quarterly Report on Form 10-Q for the quarter ended March 31, 2006.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to submit technical data files (XBRL) rather than a financial statement containing numerical results.
Material Changes
No material changes to financial performance or operations are detailed in this specific text. The filing references the submission of unaudited financial information in a new format for testing purposes.
Guidance, Outlook, and Risks
Management Commentary: The company states that the purpose of submitting these XBRL formatted documents is to test the related format and technology.
Risks and Contingencies: The filing explicitly warns that the financial information contained in the XBRL documents is unaudited and not the official publicly filed financial statements. Investors are advised to rely on the official filed version of the Form 10-Q and not on this information for investment decisions.
Legal Status: In accordance with Rule 402 of Regulation S-T, the information in this report shall not be deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liability of that section.
Important Facts for Investors to Verify
- The XBRL data attached to this 8-K is unaudited and intended for format testing only.
- Investors must refer to the official Form 10-Q filed on May 8, 2006, for authoritative financial data.
- This document does not contain the actual financial figures for the quarter ended March 31, 2006.
- The filing was signed by Sandra Leung, Secretary, on June 2, 2006.